Benzinga's Top #PreMarket Losers
December 17, 2013 at 08:28 AM EST
Targacept (NASDAQ: TRGT ) shares fell 31.93% to $4.05 in the pre-market trading after the company announced negative top-line results from Phase 2b clinical trial of TC-5619 in Schizophrenia. Rockwell Medical (NASDAQ: RMTI ) dipped 12.03% to $11.85. Brean Capital initiated coverage on the stock with a Sell
